Climb Bio Q4 EPS $(0.26) Misses $(0.18) Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings MissesNews
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 46.07 percent. This is a 100 percent decrease over losses of $(0.13) per share from the
Climb Bio (NASDAQ:CLYM) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.18) by 46.07 percent. This is a 100 percent decrease over losses of $(0.13) per share from the same period last year.